开始
Iovance Biotherapeutics, Inc.

Needed

IOVA holders/investors need an Heiken Ashi confirmed breakout with a bullish MACD crossover, with a RSI around 60. Stay safe and encouraged.
paper_Trader1775
Chart PatternsTechnical IndicatorsTrend Analysis
paper_Trader1775

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。